Search alternatives:
"c largest decrease" » "c marked decrease" (Expand Search), "_ largest decrease" (Expand Search), "c large decrease" (Expand Search)
"ct values increased" » "ct cases increased" (Expand Search), "ct dalys increased" (Expand Search), "ct also increased" (Expand Search), "_ values increased" (Expand Search), "i values increased" (Expand Search)
"_ larger decrease" » "_ marked decrease" (Expand Search), "_ large decrease" (Expand Search), "_ largest decrease" (Expand Search), "a large decrease" (Expand Search)
Showing 1 - 20 results of 41 for search '(((("c largest decrease") OR ("_ larger decrease"))) OR ("ct values increased"))*', query time: 0.47s Refine Results
  1. 1
    Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24.

    Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART.

    Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model.

    Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24.

    Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24.

    Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Consolidated Standards of Reporting Trials flow diagram for participants in the trial.

    Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24.

    Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Changes in baseline T-cell exhaustion, monocyte activation and platelet activation markers through week 12 and week 24 according to the linear regression model. a.

    Changes in baseline T-cell exhaustion, monocyte activation and platelet activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Change in Demoralization Scale (DSII) by Treatment Group.

    Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group.

    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Participants with virologic suppression or failure at week 24.

    Participants with virologic suppression or failure at week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a.

    Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Superimposition of the cephalometric tracings obtained before and after treatment of case with premolar tooth extraction.

    Superimposition of the cephalometric tracings obtained before and after treatment of case with premolar tooth extraction. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: